CN107266567B - Lcrmp4单克隆抗体及其制备方法与应用 - Google Patents
Lcrmp4单克隆抗体及其制备方法与应用 Download PDFInfo
- Publication number
- CN107266567B CN107266567B CN201710414047.6A CN201710414047A CN107266567B CN 107266567 B CN107266567 B CN 107266567B CN 201710414047 A CN201710414047 A CN 201710414047A CN 107266567 B CN107266567 B CN 107266567B
- Authority
- CN
- China
- Prior art keywords
- antibody
- monoclonal antibody
- prostate cancer
- protein
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710414047.6A CN107266567B (zh) | 2017-06-05 | 2017-06-05 | Lcrmp4单克隆抗体及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710414047.6A CN107266567B (zh) | 2017-06-05 | 2017-06-05 | Lcrmp4单克隆抗体及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107266567A CN107266567A (zh) | 2017-10-20 |
CN107266567B true CN107266567B (zh) | 2021-06-04 |
Family
ID=60065478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710414047.6A Active CN107266567B (zh) | 2017-06-05 | 2017-06-05 | Lcrmp4单克隆抗体及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107266567B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113416258B (zh) * | 2019-10-24 | 2023-08-29 | 北京免疫方舟医药科技有限公司 | 一种多特异性抗体及其制备方法和用途 |
CN111254191B (zh) * | 2020-02-24 | 2023-10-03 | 陈征 | 一种前列腺癌术后gs升级的预测方法 |
CN112410306B (zh) * | 2020-10-26 | 2023-04-28 | 广州仕韫生物技术有限公司 | 一种检测l-crmp4的双抗体夹心化学发光免疫检测试剂盒及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01168299A (ja) * | 1987-12-25 | 1989-07-03 | Mitsui Toatsu Chem Inc | モノクローナル抗体およびそれを産生するハイブリドーマ |
CA2645983A1 (en) * | 2006-03-17 | 2007-09-27 | Mcgill University | Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
CN101365806A (zh) * | 2005-12-01 | 2009-02-11 | 医学预后研究所 | 用于鉴定治疗反应的生物标记的方法和装置及其预测疗效的用途 |
CN101492504A (zh) * | 2008-01-21 | 2009-07-29 | 欧平 | 抗HnRNP B1抗原的单克隆抗体的制备及其应用 |
CN101985472A (zh) * | 2010-10-12 | 2011-03-16 | 浙江大学 | 抗结核杆菌cfp-10单克隆抗体tbcd6及应用 |
CN103076453A (zh) * | 2012-12-24 | 2013-05-01 | 何以丰 | P16免疫细胞化学试剂盒及其制备用多肽序列 |
CN106480188A (zh) * | 2016-10-17 | 2017-03-08 | 高新 | 转移性前列腺癌早期预测的分子探针、试剂盒及该分子探针的应用 |
-
2017
- 2017-06-05 CN CN201710414047.6A patent/CN107266567B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01168299A (ja) * | 1987-12-25 | 1989-07-03 | Mitsui Toatsu Chem Inc | モノクローナル抗体およびそれを産生するハイブリドーマ |
CN101365806A (zh) * | 2005-12-01 | 2009-02-11 | 医学预后研究所 | 用于鉴定治疗反应的生物标记的方法和装置及其预测疗效的用途 |
CA2645983A1 (en) * | 2006-03-17 | 2007-09-27 | Mcgill University | Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
CN101492504A (zh) * | 2008-01-21 | 2009-07-29 | 欧平 | 抗HnRNP B1抗原的单克隆抗体的制备及其应用 |
CN101985472A (zh) * | 2010-10-12 | 2011-03-16 | 浙江大学 | 抗结核杆菌cfp-10单克隆抗体tbcd6及应用 |
CN103076453A (zh) * | 2012-12-24 | 2013-05-01 | 何以丰 | P16免疫细胞化学试剂盒及其制备用多肽序列 |
CN106480188A (zh) * | 2016-10-17 | 2017-03-08 | 高新 | 转移性前列腺癌早期预测的分子探针、试剂盒及该分子探针的应用 |
Non-Patent Citations (2)
Title |
---|
Quinn CC等.TUC-4b,a Novel TUC Family Variant, Regulates Neurite Outgrowth and Associates with Vesicles in the Growth Cone.《J Neurosci》.2003,第23卷(第7期),第2815-2823页. * |
TUC-4b,a Novel TUC Family Variant, Regulates Neurite Outgrowth and Associates with Vesicles in the Growth Cone;Quinn CC等;《J Neurosci》;20030401;第23卷(第7期);第2817-2818页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107266567A (zh) | 2017-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10539566B2 (en) | Use of markers including filamin A in the diagnosis and treatment of prostate cancer | |
Yang et al. | Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases | |
Jiang et al. | Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients | |
WO2007026896A1 (ja) | 腎ガン診断、腎ガン患者予後予測のための組成物および方法 | |
CN107266567B (zh) | Lcrmp4单克隆抗体及其制备方法与应用 | |
JP6060425B2 (ja) | 膀胱癌の診断 | |
KR20160133740A (ko) | 파이브로넥틴 단백질 양성 엑소좀을 포함하는 암 진단 또는 예후 예측용 조성물 | |
Scholz et al. | Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas | |
WO2015149450A1 (zh) | Ehd2抗体及其在制备乳腺癌免疫组化检测试剂中的应用 | |
KR101680360B1 (ko) | Del-1 단백질 양성 엑소좀을 포함하는 암 진단 또는 예후 예측용 조성물 | |
EP2620772A1 (en) | Gastric cancer biomarkers and methods of use thereof | |
WO2006011587A1 (ja) | 癌細胞の悪性度判定法 | |
JP5660486B2 (ja) | ムチン1(muc1)タンパク質に対する抗体及びその用途 | |
US8257716B2 (en) | Anti-PDEF antibodies and uses thereof | |
CN108291915B (zh) | Ed-b蛋白在诊断组织增生中的应用 | |
JP2022153482A (ja) | 癌のバイオマーカーとしてのpd-ecgf | |
CN110835650B (zh) | 乳腺癌转移和预后诊断的生物标志物 | |
WO2010123124A1 (ja) | 固形がんの再発および予後因子、およびその臨床利用 | |
Chen et al. | Fibulin-5 is Down-Regulated in Colorectal Cancer and Correlated with Clinicopathologic Characteristics. | |
CN109517049B (zh) | Linc00266-1多肽作为实体瘤标志物的应用 | |
JP2017108686A (ja) | 膵癌の再発リスクの予測に用いるための診断薬及びキット、並びに予測方法 | |
CN111235276B (zh) | 去势抵抗型前列腺癌诊断和/或预后评估标志物LncRNA ZNF518A及其应用 | |
US20200408761A1 (en) | Methods of diagnosing and treating bladder cancer | |
WO2013176070A1 (ja) | 癌の検出方法 | |
JP2022006774A (ja) | 抗vegf-a抗体による癌に対する治療応答性を予測又は決定するための方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220110 Address after: 510630 No. 600 Tianhe Road, Guangzhou, Guangdong, Tianhe District Patentee after: THE THIRD AFFILIATED HOSPITAL OF SUN YAT-SEN University Patentee after: Sun Yat-sen University Address before: 600 Third Affiliated Hospital of Zhongshan University, Tianhe Road, Guangzhou, Guangdong, Tianhe District 510630, China Patentee before: Gao Xin |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220815 Address after: Room F226, Guangzhou International Business Incubator, No. 3 Lanyue Road, Science City, Huangpu District, Guangzhou City, Guangdong Province, 510700 Patentee after: Guangzhou Shikai Biotechnology Co.,Ltd. Address before: 510630 No. 600 Tianhe Road, Guangzhou, Guangdong, Tianhe District Patentee before: THE THIRD AFFILIATED HOSPITAL OF SUN YAT-SEN University Patentee before: SUN YAT-SEN University |